← European Medicine Shortage Tracker · all medicines

Buserelinacetat shortage — availability across Europe

Buserelinacetat currently has availability issues reported in 1 European register: Sweden.

MEDICALLY REVIEWED

Dr. Chrysoula I. Liakou MD, PhD

Internal Medicine Specialist
Cancer Immunology Researcher

Reviewed 30 July 2026 · next review due 30 January 2027

Shortage ATC — · also listed as: buserelinacetat · data refreshed 7 August 2026

Key facts

As of 7 August 2026, Buserelinacetat has active availability issues in 1 of 10 tracked European registers.
Registers reporting issues: Sweden.
Latest expected-resolution date on file: 2026-08-31.
Longest-running open report: since 2023-08-10 (36 months, Sweden).
Data source: 1 official medicines-agency register, refreshed daily.

As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Buserelinacetat, covering 2 affected product presentations. The longest-running open report was filed in Sweden on 2023-08-10 and has now been open for about 36 months. The furthest expected-resolution date currently on file is 2026-08-31; the earliest is 2026-08-31. Registers in Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

Where	Status & products	Since	Expected end	Reason / alternatives	Source
🇸🇪 Sweden	Shortage Suprecur 0,15 mg/dos Nässpray, lösning + 1 more products Suprefact 1 mg/ml Injektionsvätska, lösning	2023-08-10	2026-08-31	— Alternatives: Alternative(s) available — see the national register.	register ↗

Full report history (2 register entries)

Every individual register entry for Buserelinacetat in the tracked sources, newest first — including resolved and discontinued reports.

Reg.	Product	Status	Reported	Expected end	Stated reason
🇸🇪 SE	Suprefact 1 mg/ml Injektionsvätska, lösning	Shortage	2026-07-01	2026-08-31
🇸🇪 SE	Suprecur 0,15 mg/dos Nässpray, lösning	Shortage	2023-08-10	2026-08-31

Frequently asked

Is Buserelinacetat currently in shortage in Europe?

Yes. As of 7 August 2026, availability issues are reported in: Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Buserelinacetat shortage expected to end?

Agency prognoses on file range from 2026-08-31 to 2026-08-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Buserelinacetat?

2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Buserelinacetat availability data come from?

Directly from the official medicines-agency register that lists Buserelinacetat: Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Buserelinacetat — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/buserelinacetat/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Buserelinacetat availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/buserelinacetat/">Buserelinacetat shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>

Cite: “Buserelinacetat: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 7 August 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.